Recent Advances in the Development of Nanodelivery Systems Targeting the TRAIL Death Receptor Pathway

The TRAIL (TNF-related apoptosis-inducing ligand) apoptotic pathway is extensively exploited in the development of targeted antitumor therapy due to TRAIL specificity towards its cognate receptors, namely death receptors DR4 and DR5. Although therapies targeting the TRAIL pathway have encountered ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagolovich, Anne V., Gasparian, Marine E., Dolgikh, Dmitry A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961178/
https://www.ncbi.nlm.nih.gov/pubmed/36839837
http://dx.doi.org/10.3390/pharmaceutics15020515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961178/
https://www.ncbi.nlm.nih.gov/pubmed/36839837
http://dx.doi.org/10.3390/pharmaceutics15020515

Ejemplares similares